Alternative Views with Jeito’s Ksenija Pavletic
In Alternative Views, Private Equity Wire® goes behind closed doors with those in the know to get the latest on private markets. In this episode we discuss investment in therapeutics with Ksenija Pavletic, general partner and chief commercial officer at biopharma-focused firm Jeito Capital.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.